 Antibiotic resistance has become a global public health concern due to the overuse and misuse of antibiotics. A new technology called CISPR-CAS9 has been developed to combat antibiotic resistance by targeting and disabling antibiotic resistance genes or deactivating bacterial virulence factors. This technology uses phages as vehicles to deliver CISPR-CAS9 into bacteria, allowing it to target specific bacteria and disable them without harming other organisms. This article was authored by Fika Burhanu-Baltia and Sultan Abda-Nagya.